Objective To compare outcomes of patients with pure adenocarcinoma-in-situ (AIS) and mixed AIS/CIN 2/3 lesions including the incidence of AIS persistence, recurrence and progression to adenocarcinoma.
Introduction
Adenocarcinoma-in-situ (AIS) of the uterine cervix is a precursor to cervical adenocarcinoma and may co-exist with both high-grade squamous dysplasia (cervical intraepithelial neoplasia grades 2 and 3 (CIN 2/3)) and invasive carcinoma. In contrast to high-grade CIN, the incidence of AIS is increasing in absolute and relative terms. 1, 2 Following the diagnosis of AIS on cervical cytology or colposcopic biopsy it is essential that patients undergo an excisional biopsy such as a cold knife cone (CKC) biopsy or loop electrosurgical excision procedure (LEEP) to exclude a coexistent invasive malignancy. 3 In young women desiring fertility preservation, excisional biopsy may be adequate treatment providing the margins are clear. 4 To date, data on the comparative clinical outcomes of pure AIS and mixed AIS/CIN 2/3 lesions are lacking. Our objective was to investigate the risks of persistent, recurrent or progressive cervical neoplasia following the diagnosis of AIS, stratifying by lesion type ('pure' versus AIS/CIN 2/3), in a large population-based cohort.
Methods

Data sources and linkage procedure
The Western Australian Data Linkage System provided a de-identified extraction of linked data from the Cervical Cancer Registry (CSR) of Western Australia (WA) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) and the WA Death Registry (2001-2012) for all women with biopsy confirmed AIS. The CSR of WA is a legislatively mandated register of all cervical test results (HPV, cytology and histology) for WA residents.
1 Less than 0.05% of women request the removal of their demographic information and test results. 5 Data fields in the CSR of WA include cervical screening information, the type of procedure (e.g. punch biopsy, LEEP, CKC biopsy or hysterectomy), patient age, margin status, presence of co-existing CIN 2/3, lesion size, and length of the surgical specimen (measured macroscopic extent along the cervical canal).
Study data were obtained following approval from the Curtin University Human Research Ethics Committee (HREC) (project number: HR 86/2012), the Western Australian Department of Health HREC (project number: 2012/49) and the University of Notre Dame Australia HREC (project number: 016031F).
Selection of patients
Patients aged 18 years or older who had histologically confirmed AIS recorded in the CSR of WA from 2001 to 2012 were identified. Patients were then excluded if:
There was a history of previous treatment for high-grade CIN or cervical carcinoma.
AIS was initially treated with hysterectomy. Follow-up data were not available. Cervical cytology findings were classified according to the Australian Modified Bethesda System 2004. 2 Patient age at the time of excisional treatment was classified as ≤30 years or >30 years. The patients underwent excisional treatment procedures including CKC biopsy, LEEP or hysterectomy on the recommendation and advice provided by the treating specialist.
Histopathology findings
All histopathology reports were reviewed to confirm the type of excisional biopsy (CKC or LEEP), the number of tissue specimens in each procedure, the length of the specimen, the presence of concurrent high-grade CIN, and the resection margin status. The length of the surgical specimen was classified as: (i) Type I (<10 mm), (ii) Type II (>10 mm and <15 mm) or Type III (>15 mm). The number of specimens was classified as 1 or >1, the latter including both intentional two-stage procedures (LEEP followed by 'top hat' endocervical sampling) and technically difficult procedures which resulted in multiple, fragmented or incomplete specimens. Margin status was considered positive if any margin (ectocervical, endocervical or deep/circumferential) had any AIS involvement, negative if all margins were histologically clear of neoplasia, and 'indeterminate' if margins could not be assessed or were not documented.
The extent of AIS was determined whenever possible from the initial histopathology reports in one of two ways. In some specimens, the maximal extent of AIS was specifically documented, whereas in other cases the number of tissue blocks demonstrating AIS was recorded; in the latter situation, AIS extent was estimated assuming a 'standard' block width of 2.5 mm multiplied by the total number of involved blocks. 6 In the event that the lesion size and/or number of positive blocks was not reported, the specimens were recorded as 'lesion size not reported'. For those cases with a documented AIS extent, the lesion size was categorized as (i) ≤2.5 mm, (ii) >2.5 to ≤8 mm, or (iii) >8 to ≤30 mm.
Follow up
Follow up of patients potentially included cytological review, repeat CKC or LEEP biopsy and/or hysterectomy. The follow-up period was defined as the interval from the initial excisional procedure to the last follow-up procedure (e.g. cervical cytology, biopsy or hysterectomy) or death.
Principal outcomes
The principle outcomes investigated in this study were time from initial AIS excisional treatment to the patient's first instance of AIS or adenocarcinoma within 12 months (classified as 'persistence' in the follow-up period) or >12 months (classified as 'recurrence' in the surveillance period). The outcomes were mutually exclusive, as only the first event of interest that occurred for each woman was investigated in a single failure time-to-event model.
Statistics
Kaplan-Meier graphs were constructed to investigate the survivorship function (time from initial excisional procedure until a second case of biopsy-confirmed AIS and adenocarcinoma) and log-rank tests were used to assess equality of the survivorship function. Proportional hazards models were constructed after simultaneously adjusting for multiple factors to investigate the relative rate (hazard ratio) of having or, subsequently, developing a high-grade cervical lesion after the initial treatment. Models were constructed using purposeful selection of covariates including: presence of CIN 2/3, age at first excisional treatment, location of margin involved by AIS lesion, number of excised specimens and depth of excised tissue.
Statistical significance was determined as a P-value <0.05 and the 95% confidence intervals (CI) for hazard rate ratios were calculated. Violation of the proportional-hazard assumptions was assessed and biologically plausible interaction terms between variables were tested. STATA/IC 13.0 (StataCorp, College Station, TX, USA) was used for statistical analysis.
Results
Study cohort
An overview of the study cohort is presented in Figure 1 . During the study period, 707 patients underwent excisional treatment for AIS (following cervical cytology and/or a colposcopic biopsy reporting AIS, or AIS diagnosed incidentally following an excision biopsy for high grade CIN). In all, 71 patients were excluded from further analysis because follow-up data were not available or because hysterectomy was performed as the initial treatment ( Figure 1 ). For the remaining 636 patients, the mean age was 32.3 years (range AIS -adenocarcinoma-in-situ, excisional biopsy -loop electrosurgical procedure or cold knife cone biopsy. 
Surveillance period (≥12 months' post treatment)
After exclusion of the 107 women who underwent hysterectomy and/or patients censored due to documented AIS or carcinoma during the follow-up period, a total of 529 patients entered the surveillance period. Of these, 55 (10.4%) underwent a second excisional procedure or hysterectomy. Negative findings were recorded in 40 patients (72.7%), while 4 (7.3%) had low-grade changes, 2 (3.6%) had CIN 2/3 and 8 (14.5%) had recurrent AIS and 1 (1.8%) had invasive adenocarcinoma. One patient underwent a further excisional procedure for recurrent AIS and was subsequently diagnosed with adenocarcinoma. Hysterectomy was performed in a further 32 patients (29 cases were negative, 2 showed low-grade changes and 1 had CIN2/3). Of the 636 patients who entered the follow-up and surveillance periods, and underwent a further excisional procedure, a total of 47 (7.4%) had AIS and 12 (1.9%) had adenocarcinoma.
Adenocarcinoma
Overall there were 12 (1.9%) cases of invasive cervical adenocarcinoma detected in the follow-up and surveillance study periods. Of these, 6 patients had a LEEP performed initially with the majority (N = 4) of specimens submitted in multiple fragments making pathological assessment difficult. In each case, extensive AIS involving the biopsy margins was reported. Ten of the cases were pure AIS lesions.
Factors associated with disease persistence and recurrence
At 18 months after initial treatment, 8.8% (95% CI: 0.07-0.11) of the study cohort had confirmed persistence and/or recurrence of endocervical neoplasia. This varied significantly by the original lesion type, with persistent or recurrent neoplasia observed in 14.6% (95% CI: 0.10-0.20) of women with pure AIS compared to 4.6% (95% CI: 0.03-0.08) of women with mixed AIS/CIN 2/3 ( Figure 2 ). The Kaplan-Meier curve and log rank tests indicate a significant difference between the survival curves for pure AIS and mixed AIS/CIN 2/3 lesions (P-value <0.001).
Multivariate time-to-event analysis confirmed the association of lesion type with disease persistence and recurrence after adjusting for potential confounders and other factors ( Table 2) . Women with an initial pure AIS lesion were 2.3 times more likely to have persistent or recurrent endocervical neoplasia compared to women presenting with a mixed AIS/ CIN 2/3 lesion. Other factors associated with disease persistence or recurrence were age >30 years, positive endocervical or indeterminate margin involvement, and AIS lesion size >8 mm.
Discussion
Main Findings
To our knowledge this is the largest cohort study comparing the outcomes of women with pure AIS and mixed AIS/ CIN 2/3 lesions. Overall, persistent or recurrent disease was observed in 7.4% of the cohort and 1.9% were diagnosed with cervical adenocarcinoma during follow up which is consistent with the findings of a 2014 systematic review. 7 In the current study factors associated with AIS persistence and recurrence were 'pure AIS', age >30 years, positive endocervical margins and AIS lesions >8 mm. Positive ectocervical margin involvement was not associated with persistent or recurrent disease. Most specimens (81.9%) were single pass excisions and no differences were observed between those women treated by LEEP and CKC. The importance of a single pass excision has been highlighted 8 because 'multiple piece' excisions pose challenges in the pathological interpretation of margin status.
Strengths and limitations
Our study has acknowledged limitations including the relatively short median follow up (2.5 years) and the potential for selection bias. Caution should be exercised when interpreting the statistical significance of AIS lesion size, as the single imputation method used for estimation of lesion size when the number of blocks was counted could induce a measurement error in this covariate. It is possible that lesion size could be overestimated if the entire block was not affected. The absence of HPV status and lack of colposcopy data are additional limitations. Additionally, the findings of disease persistence/recurrence are conditional upon women remaining AIS-free for a period of 12 months. A further limitation of the study was the absence of central histopathology review, which would have made the results more robust. Strengths of the study include the population-based nature and size of the patient cohort. Case ascertainment was conducted through the CSR of WA, which follows quality-assurance and reporting processes. 1, 3 Furthermore, legislative requirements for the reporting of cervical histopathology to the CSR of WA would have facilitated the capture of almost all AIS cases presenting during the study period. 5 Interpretation in the light of other evidence
Older age and positive endocervical margin status are recognised risk factors for persistent/recurrent AIS. [8] [9] [10] [11] [12] [13] Lesion size >8 mm has been shown to correlate strongly with persistence/recurrence in women with incidental AIS 14 and the findings of the current study are consistent with this observation. It is notable that pure AIS was associated with more than twice the risk of disease persistence/recurrence compared with mixed AIS/CIN 2/3 lesions. 5 This observation could not be explained by differences in AIS extent, as these were comparable between the two groups. It may be that pure AIS and mixed AIS/CIN 2/3 lesions differ biologically, or that the presence of concurrent CIN leads to earlier diagnosis and treatment, as it is recognised that the cytological detection of AIS is less accurate than that of high-grade CIN. We were not able to determine whether there might have been differences in HPV subtypes between the groups.
Conclusion
In this study, pure AIS, age >30 years, positive endocervical margins and AIS lesions >8 mm were associated with higher risk of AIS persistence/recurrence. These findings require validation in prospective trials.
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